Drugs / Clostridium botulinum type A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03715777 | Oct 2018 → Apr 2019 | myopathy, pelvis syndrome | Jose Alberola-Rubio | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clostridium botulinum type A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03715777 ↗ |
| Route | Intramuscular | “Route of administration (relevant to the maximum dose): Intramuscular use” NCT03715777 ↗ |